A Trial to study the effects of two drugs travoprost & brimonidine/timolol combination in patients with kanchbind (high pressure in eyes).
Phase 4
Completed
- Conditions
- Health Condition 1: null- glaucoma
- Registration Number
- CTRI/2011/11/002105
- Lead Sponsor
- nil
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 70
Inclusion Criteria
IOP in each eye more than 21 mm Hg.
Best corrected visual acuity 6/18 or better in each eye.
Exclusion Criteria
Progressive or functionally significant visual fields loss within past year.
Pregnant women or lactating mothers.
Patients with corneal abnormalities or any other conditions that prevent applanation tonometry.
Patients with ocular infection, advanced cataract, ocular inflammation.
Patients of bronchial asthma & cardiac disease. Â
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Visual acuity <br/ ><br> <br/ ><br>IOP <br/ ><br> <br/ ><br>Slit lamp Bimicroscopy for optic disc evaluation <br/ ><br> <br/ ><br>Gonioscopy <br/ ><br> <br/ ><br>PerimetryTimepoint: 4, 8, 12 wks
- Secondary Outcome Measures
Name Time Method Visual acuity <br/ ><br> <br/ ><br>IOP <br/ ><br> <br/ ><br>Slit lamp Bimicroscopy for optic disc evaluation <br/ ><br> <br/ ><br>Gonioscopy <br/ ><br> <br/ ><br>Perimetry <br/ ><br>Timepoint: 4, 8, 12 wks